NDT Pharmaceuticals Inc. (NDTP)
OTCMKTS · Delayed Price · Currency is USD
0.3500
0.00 (0.00%)
Oct 9, 2026, 9:53 AM EST
NDT Pharmaceuticals Market Cap
NDT Pharmaceuticals has a market cap or net worth of $66.87 million as of October 9, 2026. It is the 28,284th most valuable company in the world and the 4,455th biggest in the United States. Its market cap has decreased by 67.43% in one year.
Market Cap
66.87M
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#4,455 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since October 21, 2011, NDT Pharmaceuticals's market cap has increased from 2.76M to 66.87M, an increase of 2,323.56%. That is a compound annual growth rate of 23.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 66.87M | -74.62% |
| Dec 31, 2025 | 263.50M | 3,007.18% |
| Dec 31, 2024 | 8.48M | -13.47% |
| Dec 28, 2023 | 9.80M | 1,785.32% |
| Dec 31, 2021 | 519.82K | -69.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BetterLife Pharma | 117.42M |
| Vaxart | 106.98M |
| HST Global | 99.00M |
| Nuo Therapeutics | 62.96M |
| ProText Mobility | 61.54M |
| Sangamo Therapeutics | 58.00M |
| Arch Biopartners | 39.31M |
| Cell Source | 37.55M |